Recurrent or Refractory PTCL
1 clinical trials · Condition
◉ Watch Recurrent or Refractory PTCL
| Record | Firm | Date |
|---|---|---|
| Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients (NCT01776411) | Mundipharma K.K. | 2013-01-01 |
Track Recurrent or Refractory PTCL automatically
Every clearance here is in the API, with alerts when new ones post.